HER-2 Positive Breast Cancer Unknown Status Phase 2 Trials for Paclitaxel (DB01229)

IndicationStatusPhase
DBCOND0042425 (HER-2 Positive Breast Cancer)Unknown Status2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01428414Efficacy and Safety Study of Trastuzumab and Paclitaxel Based Regimens to Treat HER2-positive Breast CancerTreatment